Clinical trial Recruiting at 1 site Phase 3 Interventional Ages 10 to 18 Women only

Micronutrient Enhancement for Development and Health in Adolescent Girls

Official title: Micronutrient Enhancement for Development and Health in Adolescents

Run by Johns Hopkins Bloomberg School of Public Health · NCT07695883 · Data updated 2026-11-12

This study tests whether daily micronutrient supplements (MMS or MMS+), compared with weekly iron-folic acid, can improve school performance and growth in 10- to 18-year-old girls in rural Bangladesh.

Quick facts

PhasePhase 3
Study typeInterventional
Ages10 Years to 18 Years
SexWomen only
Enrollment3000 (estimated)
SponsorJohns Hopkins Bloomberg School of Public Health
Academic / other
Locations1 site (Rangpur City)
StatusRecruiting
StartedSeptember 27, 2026
Main results expectedMarch 31, 2028
Study endsJune 30, 2028
Registry record updatedOctober 9, 2026
Trial IDNCT07695883 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Unmarried girls aged 10–18 living in their parental home in the study area without major chronic conditions.

Probably not a fit

Participants with certain chronic illnesses or conditions not excluded by the study may not experience the same benefits from micronutrient supplementation.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This is a three-arm, randomized, open-label trial enrolling about 3,000 adolescent girls aged 10–18 in rural Bangladesh to compare UNIMMAP-based MMS, MMS+ (UNIMMAP plus calcium, choline, DHA, and higher vitamin D), and standard weekly iron-folic acid for 12 months. The study will assess neurodevelopment, linear growth (height-for-age z-score), bone health, biochemical nutrient status, and functional outcomes, with in-depth clinical assessments and biospecimen collection for future analyses. Primary outcomes include school achievement and height-for-age, with secondary outcomes covering neurocognitive function, bone health, and nutrient biomarkers. The trial is conducted under an individually randomized, open-label design at multiple sites, led by Johns Hopkins Bloomberg School of Public Health, with collaboration from ICDDR,B and the Gates Foundation, and plans to inform nutrition policies for adolescents.

Why it matters

Potential benefit: If successful, the intervention could improve growth, cognitive function, and overall health in adolescent girls and inform nutrition policies for LMIC settings.

How similar studies have gone: Prior studies of micronutrient supplementation in adolescents show potential benefits, but this targeted three-arm MMS/MMS+ vs. iron-folic acid in this age group is relatively novel.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Unmarried 10-18 year old females
* living in their parental home in the study area

Exclusion Criteria:

* Married females under 18 years old;
* those with a history or diagnosis of chronic or congenital heart disease, chronic kidney or lung disease, cancer, and epilepsy

Where it's running

  • JiVitA Project Head Quarters
    Rangpur City, Bangladesh
    Recruiting

Study contacts

  • Principal investigator: Parul Christian, DrPH — Johns Hopkins University
  • Study coordinator: Parul Christian, DrPH
  • Email: pchrist1@jhu.edu
  • Phone: 14109552061

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.